Swanton H
Middlesex Hospital, London.
Br J Hosp Med. 1991 Oct;46(4):217-8.
I have tried to highlight some of the extraordinary advances in cardiology over the last 25 years. Many conditions, however, such as primary pulmonary hypertension or cardiogenic shock remain as refractory to treatment now as then. There is no room for complacency. In addition the increasing cost of technology and the increasing demand for interventional cardiology are not being met. We are far behind our European colleagues in being able to provide this service.
我试图强调过去25年来心脏病学领域取得的一些非凡进展。然而，许多病症，如原发性肺动脉高压或心源性休克，如今仍像过去一样难以治疗。我们没有自满的余地。此外，技术成本不断上升，而对介入心脏病学的需求却未得到满足。在提供这项服务方面，我们远远落后于欧洲同行。
